| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3599 |
| Trial ID | NCT06056102 |
| Disease | Kidney Transplant | Kidney Failure |
| Altered gene | BCMA|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells|CD19 CAR-T cells |
| Recruitment status | Not Recruiting |
| Title | CAR-T Cell Therapy for Desensitization in Kidney Transplantation |
| Year | 2024 |
| Country | United States |
| Company sponsor | National Institute of Allergy and Infectious Diseases |
| Other ID(s) | DAIT CTOT-46 |
| Cohort1: dose level 1 | |||||||||||||
|
|||||||||||||
| Cohort2: dose level 2 | |||||||||||||
|
|||||||||||||
| Cohort3: dose level 3 | |||||||||||||
|
|||||||||||||